AELIX Therapeutics

AELIX Therapeutics is a clinical-stage biotechnology company focused on developing therapeutic HIV vaccines for treatment/eradication strategies. AELIX Therapeutics is a spin-off from HIVACAT, a public-private partnership in Catalonia conducting cutting-edge research in the field. AELIX holds the global exclusive license for the development and commercialization of the HTI immunogen.